Expression of Epidermal Growth Factor Receptors (EGFR) on Breast Carcinomas in Relation to Growth Fractions, Estrogen Receptor Status and Morphological Criteria-Reference-Cited by-同舟云学术

Expression of Epidermal Growth Factor Receptors (EGFR) on Breast Carcinomas in Relation to Growth Fractions, Estrogen Receptor Status and Morphological Criteria

Published:1988-02 Issue:1 Volume:183 Page:17-24
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Wrba Friedrich,Reiner Angelika,Ritzinger Eva,Heinrich Holzner J.,Reiner Georg

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference32 articles.

1. Problems in breast pathology;Azzopardi;In: Major problems in pathology. WB Saunders Ltd,1979

2. Methods for growth of cultured cells in serum-free medium;Barnes;Anal Biochem,1980

3. Epidermal growth factor stimulates secretion of human chorionic gonadotropin by cultured human choriocarcinoma cells;Benevist;J Clin Endocrinol Metab,1978

4. Down regulation of epidermal growth factor receptor in KB cells is due to receptor internalization and subsequent degradation in lysosomes;Berguinot;Proc Natl Acad Sci USA,1984

5. Histological grading and prognosis in breast cancer;Bloom;A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer,1957

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidermal growth factor receptor signalling in human breast cancer cells operates parallel to estrogen receptor α signalling and results in tamoxifen insensitive proliferation;BMC Cancer;2014-04-23

2. Developments in Epidermal Growth Factor Receptor-Targeting Therapy for Solid Tumors: Focus on Matuzumab (EMD 72000);Cancer Investigation;2008-01

3. Highlights From: the 41st Annual Meeting of the American Society of Clinical Oncology; Orlando, FL May 2005;Clinical Breast Cancer;2005-08

4. Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trial;The Lancet Oncology;2005-06

5. Type 1 Protein Tyrosine Kinases in Chinese Breast Carcinomas;International Journal of Surgical Pathology;2001-07